2-(4,6-Diphenyl-1,3,5-triazin-2-yl)-5-(hexyloxy)phenol>98.0%(HPLC)(T)200g

Ethyl 3,5-Dimethylisoxazole-4-carboxylate>98.0%(GC)5g

1H-Thieno[3,2-d][1,3]oxazine-2,4-dione, 95.0%, 100mg

2-Pyridinamine, 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-, hydrochloride (1:1), 5mg

ethyl (5-amino-1H-tetrazol-1-yl)acetate, 95.0%, 5g

4-Methoxyphenyl 2,3,4,6-Tetra-O-acetyl-beta-D-galactopyranoside>98.0%(HPLC)5g

5,6-Difluoro-1H-1,3-benzodiazol-2-amine, 95%, 100mg

2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole, 95+%, 1g

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 1g

L-Prolina, minimo 98,5%, Ph.Eur., per biochimica, 25 g, confezione in plastica.

Cyclohexanecarbonitrile, 95.0%, 25g

(6-Bromo-naphthalen-2-yloxy)-acetic acid hydrazide, 97.0%, 1g

Boc-4-(trifluoromethyl)-L-phenylalaninol, 250mg